Michael J. Jung

Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C.4.1.1.17) by substrate and product analogs

Brian W. Metcalf, Philippe Bey, Charles Danzin et al. · Journal of the American Chemical Society · 1978 · 1K citations

Drug Target, Altmetric Attention Score, Chemical Biology +19

γ‐VINYL GABA (4‐amino‐hex‐5‐enoic acid), A NEW SELECTIVE IRREVERSIBLE INHIBITOR OF GABA‐T: EFFECTS ON BRAIN GABA METABOLISM IN MICE¹

Michael J. Jung, Bruce Lippert, Brian W. Metcalf et al. · Journal of Neurochemistry · 1977 · 479 citations

Molecular Pharmacology, γ‐Vinyl Gaba, Brain Gaba Metabolism +14

Do Firms Strategically Disseminate? Evidence from Corporate Use of Social Media

Michael J. Jung, James P. Naughton, Ahmed Tahoun et al. · The Accounting Review · 2017 · 348 citations

Social Medium Monitoring, Communication, Journalism +19

THE EFFECT OF 4‐AMINO HEX‐5‐YNOIC ACID (γ‐ACETYLENIC GABA, γ‐ETHYNYL GABA) A CATALYTIC INHIBITOR OF GABA TRANSAMINASE, ON BRAIN GABA METABOLISM <i>IN VIVO</i>

Michael J. Jung, Bruce Lippert, Brian W. Metcalf et al. · Journal of Neurochemistry · 1977 · 217 citations

Neuromodulation Therapies, Experimental Pharmacology, Social Sciences +21

Do Investors Benefit from Selective Access to Management?

Brian J. Bushee, Michael J. Jung, Gregory S. Miller · Journal of Financial Reporting · 2017 · 147 citations

Market Microstructure, Corporate Managers, Mergers And Acquisitions +13